572 research outputs found
Identification of rhabdoviral sequences in oropharyngeal swabs from German and Danish bats
BACKGROUND: In the frame of active lyssavirus surveillance in bats, oropharyngeal swabs from German (N = 2297) and Danish (N = 134) insectivorous bats were investigated using a newly developed generic pan-lyssavirus real-time reverse transcriptase PCR (RT-qPCR). FINDINGS: In total, 15 RT-qPCR positive swabs were detected. Remarkably, sequencing of positive samples did not confirm the presence of bat associated lyssaviruses but revealed nine distinct novel rhabdovirus-related sequences. CONCLUSIONS: Several novel rhabdovirus-related sequences were detected both in German and Danish insectivorous bats. The results also prove that the novel generic pan-lyssavirus RT-qPCR offers a very broad detection range that allows the collection of further valuable data concerning the broad and complex diversity within the family Rhabdoviridae
Oral Rabies Vaccines – Background in terms of historical development, technical specifications, current production situation, research updates
Estimating the global burden of endemic canine rabies
Background: Rabies is a notoriously underreported and neglected disease of lowincome
countries. This study aims to estimate the public health and economic burden
of rabies circulating in domestic dog populations, globally and on a country-by-country
basis, allowing an objective assessment of how much this preventable disease costs
endemic countries.<p></p>
Methodology/Principal Findings: We established relationships between rabies mortality
and rabies prevention and control measures, which we incorporated into a model
framework. We used data derived from extensive literature searches and
questionnaires on disease incidence, control interventions and preventative measures
within this framework to estimate the disease burden. The burden of rabies impacts on
public health sector budgets, local communities and livestock economies, with the
highest risk of rabies in the poorest regions of the world. This study estimates that
globally canine rabies causes approximately 59,000 (95% Confidence Intervals: 25-
159,000) human deaths, over 3.7 million (95% CIs: 1.6-10.4 million) disability-adjusted
life years (DALYs) and 8.6 billion USD (95% CIs: 2.9-21.5 billion) economic losses
annually. The largest component of the economic burden is due to premature death
(55%), followed by direct costs of post-exposure prophylaxis (PEP, 20%) and lost
income whilst seeking PEP (15.5%), with only limited costs to the veterinary sector due
to dog vaccination (1.5%), and additional costs to communities from livestock losses
(6%).<p></p>
Conclusions/Significance: This study demonstrates that investment in dog vaccination,
the single most effective way of reducing the disease burden, has been inadequate
and that the availability and affordability of PEP needs improving. Collaborative
investments by medical and veterinary sectors could dramatically reduce the current
large, and unnecessary, burden of rabies on affected communities. Improved
surveillance is needed to reduce uncertainty in burden estimates and to monitor the
impacts of control efforts.<p></p>
Spatio-temporal Analysis of the Genetic Diversity of Arctic Rabies Viruses and Their Reservoir Hosts in Greenland
There has been limited knowledge on spatio-temporal epidemiology of zoonotic arctic fox rabies among countries bordering the Arctic, in particular Greenland. Previous molecular epidemiological studies have suggested the occurrence of one particular arctic rabies virus (RABV) lineage (arctic-3), but have been limited by a low number of available samples preventing in-depth high resolution phylogenetic analysis of RABVs at that time. However, an improved knowledge of the evolution, at a molecular level, of the circulating RABVs and a better understanding of the historical perspective of the disease in Greenland is necessary for better direct control measures on the island. These issues have been addressed by investigating the spatio-temporal genetic diversity of arctic RABVs and their reservoir host, the arctic fox, in Greenland using both full and partial genome sequences. Using a unique set of 79 arctic RABV full genome sequences from Greenland, Canada, USA (Alaska) and Russia obtained between 1977 and 2014, a description of the historic context in relation to the genetic diversity of currently circulating RABV in Greenland and neighboring Canadian Northern territories has been provided. The phylogenetic analysis confirmed delineation into four major arctic RABV lineages (arctic 1-4) with viruses from Greenland exclusively grouping into the circumpolar arctic-3 lineage. High resolution analysis enabled distinction of seven geographically distinct subclades (3.I - 3.VII) with two subclades containing viruses from both Greenland and Canada. By combining analysis of full length RABV genome sequences and host derived sequences encoding mitochondrial proteins obtained simultaneously from brain tissues of 49 arctic foxes, the interaction of viruses and their hosts was explored in detail. Such an approach can serve as a blueprint for analysis of infectious disease dynamics and virus-host interdependencies. The results showed a fine-scale spatial population structure in Greenland arctic foxes based on mitochondrial sequences, but provided no evidence for independent isolated evolutionary development of RABV in different arctic fox lineages. These data are invaluable to support future initiatives for arctic fox rabies control and elimination in Greenland
A Step Forward in Molecular Diagnostics of Lyssaviruses – Results of a Ring Trial among European Laboratories
Rabies is a lethal and notifiable zoonotic disease for which diagnostics have to meet the highest standards. In recent years, an evolution was especially seen in molecular diagnostics with a wide variety of different detection methods published. Therefore, a first international ring trial specifically designed on the use of reverse transcription polymerase chain reaction (RT-PCR) for detection of lyssavirus genomic RNA was organized. The trial focussed on assessment and comparison of the performance of conventional and real-time assays. In total, 16 European laboratories participated. All participants were asked to investigate a panel of defined lyssavirus RNAs, consisting of Rabies virus (RABV) and European bat lyssavirus 1 and 2 (EBLV-1 and -2) RNA samples, with systems available in their laboratory. The ring trial allowed the important conclusion that conventional RT-PCR assays were really robust assays tested with a high concordance between different laboratories and assays. The real-time RT-PCR system by Wakeley et al. (2005) in combination with an intercalating dye, and the combined version by Hoffmann and co-workers (2010) showed good sensitivity for the detection of all RABV samples included in this test panel. Furthermore, all used EBLV-specific assays, real-time RT-PCRs as well as conventional RT-PCR systems, were shown to be suitable for a reliable detection of EBLVs. It has to be mentioned that differences were seen in the performance between both the individual RT-PCR systems and the laboratories. Laboratories which used more than one molecular assay for testing the sample panel always concluded a correct sample result. Due to the markedly high genetic diversity of lyssaviruses, the application of different assays in diagnostics is needed to achieve a maximum of diagnostic accuracy. To improve the knowledge about the diagnostic performance proficiency testing at an international level is recommended before using lyssavirus molecular diagnostics e.g. for confirmatory testing
Commercially available Rapid Immunochromatographic Test kits (LFDs) for rabies diagnosis in brain material fail in interlaboratory comparison
- …
